Document Detail


Eisenmenger's syndrome: current management.
MedLine Citation:
PMID:  12411974     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Eisenmenger's syndrome describes the elevation of pulmonary arterial pressure to the systemic level caused by increased pulmonary vascular resistance with reversal or bi-directional shunting through a large intracardiac or extracardiac congenital heart defect. This article reviews the natural history and pathophysiology of Eisenmenger's syndrome untreated and medical and surgical treatment options presently available. Although there is no cure for this condition at present, recent advances in management have improved the quality of life for many patients with Eisenmenger's syndrome.
Authors:
Erika Berman Berman; Robyn J Barst
Related Documents :
18720094 - Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in t...
9278484 - Reduced rna polymerase ii transcription in extracts of cockayne syndrome and xeroderma ...
15372524 - A case of adams-oliver syndrome with associated brain and pulmonary involvement: furthe...
12797454 - Specific congenital heart defects in rsh/smith-lemli-opitz syndrome: postulated involve...
22273654 - Acute respiratory distress syndrome with miliary tuberculosis.
16155424 - Hemihyperplasia with ehlers-danlos syndrome like skin changes.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Progress in cardiovascular diseases     Volume:  45     ISSN:  0033-0620     ISO Abbreviation:  Prog Cardiovasc Dis     Publication Date:    2002 Sep-Oct
Date Detail:
Created Date:  2002-11-04     Completed Date:  2002-12-02     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0376442     Medline TA:  Prog Cardiovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  129-38     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2002, Elsevier Science (USA). All rights reserved.
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, Columbia University, College of Physicians and Surgeons, New York, NY, USA. esb14@columbia.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use
Eisenmenger Complex / diagnosis,  therapy*
Epoprostenol / therapeutic use
Humans
Hypertension, Pulmonary / physiopathology
Pulmonary Artery / pathology
Vascular Resistance / physiology
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 35121-78-9/Epoprostenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Primary pulmonary hypertension: Current therapy.
Next Document:  The role of low-molecular-weight heparin in cardiovascular diseases.